Neuropace
NPCE
NPCE
48 hedge funds and large institutions have $103M invested in Neuropace in 2024 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
5% less capital invested
Capital invested by funds: $109M → $103M (-$5.97M)
6% less funds holding
Funds holding: 51 → 48 (-3)
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
Holders
48
Holding in Top 10
1
Calls
$9K
Puts
$1K
Top Buyers
| 1 | +$3.35M | |
| 2 | +$820K | |
| 3 | +$376K | |
| 4 |
BlackRock
New York
|
+$236K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$192K |
Top Sellers
| 1 | -$1.68M | |
| 2 | -$440K | |
| 3 | -$291K | |
| 4 |
Two Sigma Investments
New York
|
-$250K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$246K |